- Thread starter
- #61
BellaCarter
Well-known member
Member
- Joined
- Jul 23, 2026
- Messages
- 147
- Points
- 16
Retatrutide is a GLP-1/GIP/GCGR triple receptor agonist, simultaneously activating three intestinal hormone receptors. Compared to dual-target molecules, it has a stronger metabolic regulatory effect.
1. Weight Management: By suppressing appetite and delaying gastric emptying, it reduces food cravings and lowers calorie intake; simultaneously, it regulates energy metabolism, aiding in weight loss. Clinical data shows that its weight loss effect is superior to many similar dual-target molecules.
2. Blood Glucose Regulation: The GLP-1 pathway can promote insulin secretion and inhibit glucagon, helping to stabilize blood sugar and improving insulin sensitivity.
3. Comprehensive Metabolic Benefits: It can help improve blood lipids and liver fat metabolism, positively impacting metabolic syndrome-related indicators.








